Last reviewed · How we verify
NCT04046497
Artificial Intelligence to Measure Adherence to Oral Medication
Phase 4 trial testing Smartphone App in First Episode Psychosis in 200 participants. Currently enrolling.
30 November 2024
Quick facts
| Lead sponsor | Northwell Health |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 200 |
| Start date | 20 November 2020 |
| Primary completion | 30 November 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Smartphone App
- Usual Care
Conditions studied
- First Episode Psychosis — all drugs for First Episode Psychosis →
Sponsor
Northwell Health — full company profile →
Who can join
Adults 15 to 40, any sex, with First Episode Psychosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04046497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Smartphone App
Trials testing the same drug.
- NCT07165561 — Evaluation of an App for Young People With Suicidal Thoughts · NA · recruiting
- NCT05785533 — A Mobile Recovery Guidance App for Children and Young Adults With Acute Ankle Inversion Injuries · NA · recruiting
- NCT06114199 — Enhancing the Effectiveness of Home-delivery Based Produce Prescription Program Implementation Strategies · NA · recruiting
- NCT06923033 — Aim 1: App for Reducing Cravings to Smoke · NA · completed
- NCT04896593 — Mobile Technology for Reducing and Preventing Adolescent Suicide · NA · completed
Other recruiting trials for First Episode Psychosis
Currently open trials in the same condition.
- NCT06774417 — Digital Strategies to Advance Help-Seeking - Aim 3 · NA · recruiting
- NCT06774430 — Digital Strategies to Advance Help-Seeking Aim 1 and 2 · recruiting
- NCT05310838 — Optimizing Engagement in Services for First-Episode Psychosis · NA · active not recruiting
- NCT04005378 — Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs · Phase 4 · recruiting
- NCT04004364 — Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes · recruiting
Other Northwell Health trials
Trials by the same sponsor.
- NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
- NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
- NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
- NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
- NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04046497 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwell Health
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04046497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing